Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Short Interest Down 42.3% in October

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a significant drop in short interest in the month of October. As of October 15th, there was short interest totalling 1,500 shares, a drop of 42.3% from the September 30th total of 2,600 shares. Based on an average trading volume of 16,300 shares, the short-interest ratio is currently 0.1 days.

Reviva Pharmaceuticals Stock Down 9.2 %

RVPHW stock opened at $0.11 on Friday. Reviva Pharmaceuticals has a fifty-two week low of $0.07 and a fifty-two week high of $1.72. The business has a 50-day moving average of $0.13 and a 200-day moving average of $0.24.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.